Premium
Cardiac medication management in Duchenne muscular dystrophy
Author(s) -
Wittekind Samuel G.,
Villa Chet R.
Publication year - 2021
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.25175
Subject(s) - medicine , duchenne muscular dystrophy , muscular dystrophy , heart failure , respiratory failure , intensive care medicine , physical therapy
There have been significant improvements in the skeletal muscle and respiratory care for patients with Duchenne muscular dystrophy (DMD) over the last two decades. This has resulted in longer expected survival as many patients will live into their 20s and 30s. This timeline has resulted in a greater proportion of patients experiencing heart failure and cardiac‐related mortality. Herein, we describe the current indications for medical therapy for patients with DMD.